Melanoma CSCs can be identified by surface markers, such as cluster of differentiation (CD) 133, CD20, CD271, aldehyde dehydrogenases (ALDHs), and ATP-binding cassette sub-family B member 5 (ABCB5), which are associated with their tumorigenic potential and resistance to treatment. This evidence concerns the gene NGFR and melanoma.